SEBI-regulated equity research across Intraday, Swing, Investing, Options and Hero Zero strategies — every recommendation with clear entry, targets and stop-loss, published from Mumbai.
Operated by Chetankumar Divakar Amin (SEBI RA INH000028185) under SEBI (Research Analysts) Regulations, 2014.
SEBI-regulated research across all major segments. PAN-based KYC verification is mandatory before activation.
Pre-market equity research for same-day NSE trades — every idea with entry, two targets and stop-loss.
Positional research ideas for 2–15 day holding periods using pattern-based, systematic analysis.
Fundamental long-term research for wealth creation. Quarterly deep-dive reports with complete rationale.
Weekly F&O research with strike selection, OI analysis, IV rank and PCR context for informed decisions.
Expiry-day, high-conviction research setups. For experienced traders who understand and accept elevated risk.
⚠️ KYC Mandatory: As per SEBI regulations, PAN-based KYC verification is required before any subscription is activated. All services constitute research only and are not personalised investment advice. Investment in securities market is subject to market risks.
Every research note published under INH000028185 carries a name, a SEBI registration, and a complete, written rationale.
Registered under SEBI (Research Analysts) Regulations, 2014. Registration No. INH000028185. BSE Enlisted #7286.
Every recommendation includes a defined entry zone, two price targets, a stop-loss level, and complete written reasoning — no tip without rationale.
As per SEBI regulations, no personal positions are taken in covered securities for 30 days after publication. Research is independent and unbiased.
Grievances addressed via SEBI SCORES. Dispute resolution available through SMART ODR. Investor Charter published on this website.
⚠️ Important Risk Disclaimer
Investment in securities market is subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Past performance is not indicative of future results. Research published on this platform is for informational purposes only and does not constitute personalised investment advice. Investors must conduct their own due diligence. Research Analyst: Chetankumar Divakar Amin | SEBI RA: INH000028185 | BSE Enlistment: 7286.
All investor protection resources mandated by SEBI are available below. For grievances, please use the escalation path provided.
Rights of investors, services offered, fees, and grievance redressal mechanism as required under SEBI Circular SEBI/HO/MIRSD/MIRSD-SEC-5/P/CIR/2023/022.
Read Investor Charter →Mandatory disclosures about the Research Analyst, conflict of interest policy, financial interests, and research methodology as per SEBI RA Regulations 2014.
View Disclosures →Unresolved grievances can be escalated to SEBI through the SCORES platform within 30 days of our acknowledgement.
Go to SCORES ↗Disputes can be resolved through SMART ODR — the SEBI-mandated online dispute resolution portal for securities market intermediaries.
Access SMART ODR ↗Anti-Money Laundering policy aligned with SEBI Master Circular and PMLA Act. PAN KYC is mandatory before onboarding via the KRA system.
View AML Policy →Verify the research analyst's SEBI registration directly on the official SEBI website. SEBI RA Registration No. INH000028185.
Verify on SEBI.gov.in ↗As a SEBI Registered Research Analyst (INH000028185), Chetankumar Divakar Amin is committed to providing unbiased, research-based investment recommendations in full compliance with SEBI (Research Analysts) Regulations, 2014.
Research Analyst: Chetankumar Divakar Amin | SEBI RA: INH000028185 | BSE Enlistment: 7286 | Validity: Jun 15, 2026 – Perpetual
Investors with grievances should follow the escalation path below:
Compliance Officer: Chetankumar Divakar Amin | chetanamin_1@hotmail.com
This policy aligns with SEBI Master Circular SEBI/HO/MIRSD/MIRSD-SEC-5/P/CIR/2023/022 and the Prevention of Money Laundering Act, 2002. As a Research Analyst, CDA Research does not hold or manage client funds.